Atlas FDA

VNS THERAPY SYSTEM, VNS THERAPY PROGRAMMING SOFTWARE (V11.0.4)

FDA premarket approval P970003/S183 · decided 2015-10-28

Approval details

PMA number
P970003
Supplement
S183
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
VNS THERAPY SYSTEM, VNS THERAPY PROGRAMMING SOFTWARE (V11.0.4)
Generic name
Stimulator, autonomic nerve, implanted (depression)
Applicant
LivaNova USA, Inc.
Date received
2015-07-29
Decision date
2015-10-28
Days to decision
91 days
Decision code
APPR
Product code
MUZ
Advisory committee
Neurology
Expedited review
No
Location
Houston, TX
Statement
APPROVAL FOR THE INTRODUCTION OF THE MOTION CL910 AND MINOR MODIFICATIONS AND ENHANCEMENTS TO THE VNS THERAPY PROGRAMMING SOFTWARE MODEL 250 VERSION 11.0.4.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Venous Return Cannulae (K250937)LivaNova USA, Inc.2026-03-11
RAP Femoral Venous Cannulae (K250283)LivaNova USA, Inc.2025-07-10
SMARxT Tubing and Connectors (K233702)LivaNova USA, Inc.2024-08-08